207 related articles for article (PubMed ID: 33909135)
1. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry.
Arndt AT; Brunelli A; Cicconi S; Falcoz PE; Salati M; Kozower B; Liptay MJ; Rocco G; Karush JM; Geissen N; Basu S; Seder CW
Lung; 2021 Jun; 199(3):311-318. PubMed ID: 33909135
[TBL] [Abstract][Full Text] [Related]
2. Surgically Managed Clinical Stage IIIA-Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database.
Boffa D; Fernandez FG; Kim S; Kosinski A; Onaitis MW; Cowper P; Jacobs JP; Wright CD; Putnam JB; Furnary AP
Ann Thorac Surg; 2017 Aug; 104(2):395-403. PubMed ID: 28527969
[TBL] [Abstract][Full Text] [Related]
3. Variation in Pulmonary Resection Practices Between The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons General Thoracic Surgery Databases.
Seder CW; Salati M; Kozower BD; Wright CD; Falcoz PE; Brunelli A; Fernandez FG
Ann Thorac Surg; 2016 Jun; 101(6):2077-84. PubMed ID: 27021033
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
[TBL] [Abstract][Full Text] [Related]
5. The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer.
Broderick SR; Grau-Sepulveda M; Kosinski AS; Kurlansky PA; Shahian DM; Jacobs JP; Becker S; DeCamp MM; Seder CW; Grogan EL; Brown LM; Burfeind W; Magee M; Raymond DP; Puri V; Chang AC; Kozower BD
Ann Thorac Surg; 2020 Mar; 109(3):848-855. PubMed ID: 31689407
[TBL] [Abstract][Full Text] [Related]
6. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
[TBL] [Abstract][Full Text] [Related]
7. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
[TBL] [Abstract][Full Text] [Related]
8. The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes.
Fernandez FG; Kosinski AS; Burfeind W; Park B; DeCamp MM; Seder C; Marshall B; Magee MJ; Wright CD; Kozower BD
Ann Thorac Surg; 2016 Aug; 102(2):370-7. PubMed ID: 27209606
[TBL] [Abstract][Full Text] [Related]
9. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
[TBL] [Abstract][Full Text] [Related]
10. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
11. Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons General Thoracic Surgery Database for Lobectomy.
Tong BC; Kim S; Kosinski A; Onaitis MW; Boffa DJ; Habib RH; Putnam JB; Furnary AP; Cowper P; Wright CD; Jacobs JP; Fernandez FG
Ann Thorac Surg; 2019 Mar; 107(3):897-902. PubMed ID: 30253162
[TBL] [Abstract][Full Text] [Related]
12. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
[TBL] [Abstract][Full Text] [Related]
13. Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?
Shah AA; Worni M; Kelsey CR; Onaitis MW; D'Amico TA; Berry MF
Ann Thorac Surg; 2013 May; 95(5):1700-7. PubMed ID: 23545195
[TBL] [Abstract][Full Text] [Related]
14. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-N2 non-small cell lung cancer.
Predina J; Suliman R; Potter AL; Panda N; Diao K; Lanuti M; Muniappan A; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2023 May; 165(5):1696-1709.e4. PubMed ID: 36610886
[TBL] [Abstract][Full Text] [Related]
16. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
17. Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
Casiraghi M; Guarize J; Sandri A; Maisonneuve P; Brambilla D; Romano R; Galetta D; Petrella F; Gasparri R; Gridelli C; De Marinis F; Spaggiari L
Clin Lung Cancer; 2019 Mar; 20(2):97-106.e1. PubMed ID: 30446406
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality after induction chemotherapy followed by surgery in IIIa-N2 non small cell lung cancer.
Borreman P; De Leyn P; Decaluwé H; Moons J; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Acta Chir Belg; 2009; 109(3):333-9. PubMed ID: 19943589
[TBL] [Abstract][Full Text] [Related]
19. [Safety and long-term outcome of sleeve lobectomy for non-small cell lung cancer].
Xie MR; Zhang X; Lin P; Chen JX; Ling YB; Fu JH; Rong TH; Zeng CG; Huang ZF
Ai Zheng; 2009 Aug; 28(8):868-71. PubMed ID: 19664335
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
Zhong C; Yao F; Zhao H
Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
